Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects
Completed · Phase 1
Conditions studied: Healthy Adult Male
In brief
This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single IV infusion of \[14C\]-VVZ-149 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 72 hours following the start of infusion to measure total radioactivity and plasma drug concentrations.
Key facts
- Study ID
- NCT04415645
- Run by
- Vivozon, Inc.
- People needed
- 6
- Starts
- 2020-02-24
- Expected to finish
- 2020-03-31
- Last updated by the study team
- 2020-06-04
Who can join
Age: 19 and older, up to 55. Sex: male. Healthy volunteers: accepted.
Where it is running
- Celerion — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.